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Abstract
Background: Intra-abdominal adhesion is one of the major problem of postoperative surgery. It causes abdominal, and gynaecological 
morbidity. Postoperative intraperitoneal chemotherapy (IPCT) has been proved to be effective in patients with advanced cancer after 
cytoreductive surgery compared to systemic chemotherapy. In recent years there are several studies have been conducted to evaluate the 
role of IPCT on cancer treatment wound healing, and adhesion formation.
Objectives: The aim of this experimental study was to evaluate the effect of intra-abdominal cisplatin on postoperative adhesion formation 
during 2nd and 4th weeks after surgery.
Method: For conducting this experimental study, 40 male Wistar rats were studied and divided into two groups of twenty animals each. 
The abdomen was prepared for laparotomy. They underwent a laparotomy through a 3 cm midline incision. Then five abrasions as 3-4 cm 
were made on cecum the peritoneal wall. Control and treatment groups were received saline 0.9% (2 ml) and cisplatin (2 mg/kg) respectively 
during laparotomy intra-abdominally. Adhesion grade score was observed 2nd and 4th weeks after laparotomy.
Results: As the results, 10% of animals in the cisplatin groups have zero adhesion score compared to control group (11%) 4th week after 
surgery that this difference was not significant (P=0.964). The control group with score 3 (44.4%), and cisplatin group with score 1 (55.6%) 
had most adhesion in the 2nd week. Most adhesion were happened with score of 1 and 3 for both control (33.3%) and cisplatin groups (40%) 
respectively, 4th week after surgery (P=0.964). Moreover, there was no significant difference between two groups as the adhesion score (0-1) 
and (2-3) in the 2nd and 4th weeks after surgery (P=0.75).
Conclusion: Administration of intra-abdominal cisplatin in rats during laparotomy could induce adhesion band similar to control 
group. It seems that notice to chemotherapeutic agents, range of doses, number of pulse therapy, time of administration after operation, 
improving their formulation, and solvents application are necessary.
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1. Background 
Intra-abdominal adhesions following surgery as a ma-
jor unsolved problem, could happen after 50% to 100% 
of all surgical interventions in the abdomen and cause 
remarkable complicates (1). Pelvic and abdominal adhee-
sions have been reported with significant gynaecological 
morbidity, such as infertility, chronic pelvic pain, small 
bowel obstruction, and difficulty with surgical complica-
tions (2).
There are some mechanical barriers for adhesion pre-
vention that has been approved by Food and Drug Ad-
ministration including hyaluronic acid/carboxymeth-
ylcellulose (Seprafil), oxidized regenerated cellulose 
(Interceed), and expanded polytetraﬂuoroethylene (Go-
re-Tex) (3). It seem that gels and hydroﬂotating, as an ef-
fective adhesion prevention agents, can be useful during 
gynaecological surgery. But, there is no evidence to show 
any improvement fertility outcome or pelvic pain(4). 
However, it has reported that there is no evidence of the 
effects of these barriers on pain or fertility outcomes in 
the women of reproductive age. There is few evidence 
about the efficacy of Interceed, Gore-Tex, and Seprafilm 
in reducing the incidence of adhesion formation follow-
ing pelvic surgery (5). It has been shown that hyaluronic 
acid/carboxymethyl membrane (HA/CMC) could reduce 
incidence, extent and severity of adhesion. However, the 
incidence of intestinal obstruction was not decreased (6).
Intraperitoneal chemotherapy (IPCT) developing as 
a new oncological treatment has been used for locore-
gional control and long-term survival (7, 8). One of the 
important problem in the patient with colonic cancer 
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is the early postoperative adhesion formation and these 
adhesions could decrease the effect of IPCT. They may in-
hibit the distribution of the antineoplastic agents (7, 9). 
In study by Khoe et al., 2009, it was shown that from the 
307 eligible patients that have received at least one dose 
of IPCT, 34% of them had developed symptomatic intesti-
nal obstruction after IP therapy. However, the incidence 
of adhesion bowel obstruction was 4%. Then, the major-
ity of the obstructions were related to the progression 
of malignant intra-abdominal disease (10). On the other 
hand, one meta-analysis has shown that IPCT could in-
crease overall survival and progression-free survival from 
advanced ovarian cancer (11).
2. Objectives
Thus, the aim of this study was to investigate the effects 
of intra-abdominal cisplatin on adhesion band forma-
tion after laparotomy in rats.
3. Material and methods
3.1. Animals
Forty male Wistar rats (200–220 g) were provided from 
the Razi Institute (Karaj, Iran. Animals were kept at con-
stant room temperature (21±2 °C) under a normal 12 
Light:12 Dark cycle with free access to food and water. All 
animal experiments were carried out in accordance with 
the European Communities Council directive of 24 No-
vember 1986 (86/609/EEC) in such a way as to minimize 
the number of animals and their suffering.
3.2. Surgery and experimental procedures
For this study, 40 male Wistar rats were used and divid-
ed into two groups of twenty animals each (n=20). Rats 
were anesthetized with ketamine (60 mg/kg i.p.) and 
xylazine (6 mg/kg i.p.) and). The abdomen was shaved 
and prepared with povidone–iodine. For laparotomy, all 
animals underwent a laparotomy through a 3 cm mid-
line incision and the cecum was identified and the sur-
geon held it gently between thumb and index fingers. 
Then five abrasions as 3-4 cm were made on cecum. Also 
the same abrasions in number and lengths were made 
on the peritoneal wall (12). Then, control and treatment 
groups were administrated saline 0.9% (2 ml) and cis-
platin (2 mg/kg) respectively during laparotomy intra-
abdominally. Finally, the cecum was placed back in the 
abdomen and the abdomen was closed in 2 layers using 
nylon string and running sutures. The rats then were 
followed daily for wound healing, and general status to 
assure no delayed postoperative complications. After 2nd 
and 4th weeks of laparotomy, half of the animals in each 
groups were transferred to the experimental room and 
animals were anesthetized and subjected to laparotomy 
through the previous midline incision. Adhesion grade 
score was given by a blind observer as follow: 0 no adhe-
sions, 1 filmy adhesion and blunt dissection, 2: strong ad-
hesion and sharp dissection, 3 very strong vascularized 
adhesions, sharp dissection (13). 
3.3. Statistical analysis 
Statistics were calculated using SPSS software. Results 
are expressed as the percent of observed adhesion as the 
adhesion grade score in each group. Statistical compari-
son between groups was estimated using with chi-square 
test. A level of P < 0.05 were considered as statistically sig-
nificant.
4. Results
Two animals of control were died after surgery on days 
1 and 3. Also, and one animals in the cisplatin group died 
on day 7. Our results showed that 11% and 10% of animals in 
the cisplatin groups have zero adhesion score compared 
to control group (11%) 2nd and 4th weeks after surgery that 
this difference was not significant (P=0.964). 
The control group with score 3 (44.4%), and cisplatin 
group with score 1 (55.6%) had most adhesion in the 2nd 
week. However, in the 4th week, most adhesion were hap-
pened with score of 1 and 3 for both control (33.3%) and 
cisplatin groups (40%) respectively that this difference 
was not significant (P=0.964) (Table 1). 
Furthermore, there was no significant difference be-
tween two groups as the adhesion score (0-1) and (2-3) in 
the 2nd and 4th weeks after surgery (P=0.75). However, it 
seems that adhesion score (2-3) of cisplatin group in the 
2nd week was lower than control. But, it was not signifi-
cant (Table 2).  
Post-operative adhesion formation in the control and 
cisplatin groups with adhesion grade scores at different 
times was shown in Fig 1-2.
Table 1. The comparison between the peritoneal adhesion grade score between two groups of control and cisplatin on 2nd and 4th 
weeks post-operation in rats 
Adhesion grade 
score
Control 4th w, n(%) Control 2nd w, n (%) Cisplatin 4th,w, n (%) Cisplatin 2nd w, n (%) P value
0 1(11%) 1(11%) 1(10%) 1(11%)
1 3(33.3%) 3(33.3%) 4(40%) 5(55.6%) 0.964
2 2(22.2%) 1(11%) 1(10%) 0(0)
3 3(33.3%) 4(44.4%) 4(40%) 3(33.3%)
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Table 2. The comparison between two groups of control and cisplatin as the adhesion score (0-1), and (2-3) on 2nd and 4th weeks 
post-operation in rats 
Adhesion grade 
score
Control 4th w, n(%) Control 2nd w, n (%) Cisplatin 4th,w, n (%) Cisplatin 2nd w, n (%) P value
Score (0-1) 4(44.4%) 4(44.4%) 5(50.0%) 6(66.7%)
Score (2-3) 5(55.6%) 5(55.6%) 5(50.0%) 3(33.3%) 0.75
Fig 1. Comparison of post-operative adhesion formation between control and cisplatin groups on the 2nd week
A: Control, score 2; B: Control, score 3; C: Treatment, score 2, D: Treatment, score 3
Fig 2. Comparison of post-operative adhesion formation between the control and cisplatin groups on the 4th week
E: Control, score 1, F: Control, score 3, G: Treatment, score 1, H: Treatment, score 3 
5. Discussion
Our result showed that intraperitoneal adhesion in-
duced by laparotomy between the two groups of saline 
and cisplatin, was not significant on the 2nd and 4thweeks 
after surgery in rats. In women with ovarian, tubal, or 
peritoneal malignancies, the rate of bowel obstruction 
due to intra-abdominal adhesions was reported 4% of 
the total number of patients after IPCT. Among the all 
type of chemotherapy agents, cisplatin has been admin-
istrated IP for patients and a fibrous coating bowel was 
seen in some of them (10). In another study, IP administ-
tration of cisplatin for treating intra-abdominal tumor 
has induced 6% abdominal adhesion (7 of 115 patients). In-
teresting issue in this study is that chemotherapy cycles 
were not happened during post-operation period. Thus, 
it was suggested that adhesion formation was related to 
the local toxicity of cisplatin not traumatic effect of sur-
gical wound (14, 15). Similarly, our study has shown that 
administration of cisplatin during laparotomy induced 
adhesion score compared to control group that has re-
ceived saline. However this difference was not significant 
compared to control. It seems that animal results could 
confirm clinical results two above clinical results.
In a study by Conroy et al., 2003, it has reported that de-
livery solution for injection, the administration way of 
drug for example injection such as pump or bolus could 
be important in adhesion formation. Phosphate-buffered 
saline (PBS) and Ringers’ lactate solution (RLS) as delivery 
solutions for IP administration of doxorubicin (Dox) and 
bleomycin respectively could not prevent adhesion forma-
tion. But, icodextren as a delivery solution for chemothera-
peutic drugs compared to both of them could significant-
ly reduce adhesion formation. Furthermore, it seems that 
administration of single injection of lowest dose of bleo-
mycin in a tumor-free animal was not effective in adhesion 
formation (16). Unlike to above study, we have used saline 
as a solution and single dose of intra-abdominal cisplatin 
(2 mg/kg) could induce peritoneal adhesion. This may be 
related to irritant properties of chemotherapeutic agents 
that we have mentioned it before (15).
On the other hand, there are some studies about the ef-
fective role of chemotherapy on the prevention of adhe-
sion formation (7, 9). Thus, it seem that type of chemom-
therapy agent in the induction or prevention of adhesion 
is effective.
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Furthermore, it has shown that application of high dose 
of Dox-loaded poly (ethylene glycol)–poly (ɛ-caprolactone)–
poly (ethylene glycol) (PECE) micelles (Dox-M) (5 mg/kg) in 
the abdominal cavity of mice could show both antitumor 
and antiadhesion effects. About the mechanism of drug, it 
seems that in the early stage after administration of Dox-
M, it inhibits re-mesothelialization of the injured sites 
and the activity of fibroblasts due to its high concentra-
tion. But, after degradation of the micelles and gradually 
decreasing the concentration of Dox, injured part of peri-
toneum starts to re-mesothelialize. The role of micelles in 
preventing adhesion is unclear. But, it seems that micelles 
by preventing the invasion of fibroblast, provide suitable 
condition for regeneration of mesothelial. Another possi-
bility is that micelles by sticking to the peritoneal wounds 
could prevent fibrinous adhesion between the adjacent 
peritoneal wounds (17). As the above study, it seems that 
the kind of formulation and uses biodegradable micelles 
for chemotherapy agent could be important in the preven-
tion of adhesion formation or severity of adhesion. 
In a case of 71-year-old man, with obstructive descend-
ing colon cancer, and massive peritoneal metastases 
which has received palliative surgery, bowel strangula-
tion was happened on day 4 of the 2nd course of chemo-
therapy, which contains irinotecan, l-leucovorin, and 
5-ﬂuorouracil (5-FU). Massive intraperitoneal adhesion 
was formed around several intestinal loops that was not 
observed in previous surgery. It seems that in parallel 
with the severe peritoneal metastases, inﬂammatory re-
actions induced by chemotherapy throughout the abdo-
men cause the formation of massive peritoneal adhesion. 
It was suggested that in patients with multiple peritoneal 
metastases, effective chemotherapy will cause peritoneal 
adhesion that should be considered (18).
Contrary to above study, multiple cycles of IP 5-FU have 
not been associated with abdominal adhesion. However, 
numerous cycles of IP mitomycin C are not well tolerated 
in patients, and appear to cause a long term adhesive pro-
cess in the abdominal cavity. Furthermore, the incidence 
of reoperations for intra-abdominal adhesions in patients 
who receives one more cycle of IP mitomyin C was signifi-
cantly higher than 5-FU (19). As above studies, it seems that 
not only chemotherapy agents, schedule, and systemic or 
IP administrative way of drug, but also severity of perito-
neal metastasis is in formation of adhesion is effective. 
The aim of this study was to investigate the effects of 
intra-abdominal administration of cisplatin on adhesion 
formation on post laparotomy rats and we have observed 
that cisplatin has no effect on post-laparotomy abdomi-
nal adhesion compared to the control group in the dif-
ferent times. However, limitation of our study may be re-
lated to short time of study, single dose of cisplatin, and 
applying saline as a solvent. 5.1. Conclusion 
Our study showed that administration of intra-abdomi-
nal cisplatin in rats undergoing laparotomy has no effect 
on post-laparotomy abdominal adhesion compared to 
the control group. It seems that attention to type of che-
motherapeutic agents, range of doses, number of pulse 
therapy, improving their formulation, and solvents appli-
cation are necessary. This study could pave the road to de-
velop new interventional clinical studies for preventing 
or reducing adhesion in patients who receiving different 
doses of chemotherapeutic agents.
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